WGS

GeneDx Holdings Corp. Class A Common Stock

84.46

USD

WGS Earnings Reports

Positive Surprise Ratio

WGS beat 12 of 17 last estimates.

71%

Next Report

Date of Next Report

Feb 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$121.71M

$0.10

Implied change from Q3 25 (Revenue/ EPS)

+4.26%

-79.59%

Implied change from Q4 24 (Revenue/ EPS)

+27.26%

-83.87%

GeneDx Holdings Corp. Class A Common Stock earnings per share and revenue

On Oct 28, 2025, WGS reported earnings of 0.49 USD per share (EPS) for Q3 25, beating the estimate of 0.42 USD, resulting in a 14.73% surprise. Revenue reached 116.74 million, compared to an expected 105.72 million, with a 10.43% difference. The market reacted with a +5.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of 0.10 USD, with revenue projected to reach 121.71 million USD, implying an decrease of -79.59% EPS, and increase of 4.26% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Danaher Corporation

Report Date

Jan 28, 2026 For Q4 25

Estimate

$2.17

Actual

$2.23

Surprise

+2.56%

HCA Healthcare, Inc.

Report Date

Jan 27, 2026 For Q4 25

Estimate

$7.53

Actual

$8.14

Surprise

+8.05%

Elevance Health, Inc.

Report Date

Jan 28, 2026 For Q4 25

Estimate

$3.12

Actual

$3.33

Surprise

+6.46%

Cencora, Inc.

Report Date

Feb 04, 2026 For Q1 26

Estimate

$4.07

Actual

$4.08

Surprise

+0.16%

Revvity, Inc.

Report Date

Feb 02, 2026 For Q4 25

Estimate

$1.58

Actual

$1.70

Surprise

+7.45%

InnovAge Holding Corp. Common Stock

Report Date

Feb 03, 2026 For Q2 26

Estimate

$0.04

Actual

$0.08

Surprise

+96.08%

Embecta Corp. Common Stock

Report Date

Feb 05, 2026 For Q1 26

Estimate

$0.68

Actual

$0.71

Surprise

+3.89%

FAQ

What were GeneDx Holdings Corp. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, GeneDx Holdings Corp. Class A Common Stock reported EPS of $0.49, beating estimates by 14.73%, and revenue of $116.74M, 10.43% above expectations.

How did the market react to GeneDx Holdings Corp. Class A Common Stock's Q3 2025 earnings?

The stock price moved up 5.21%, changed from $130.66 before the earnings release to $137.47 the day after.

When is GeneDx Holdings Corp. Class A Common Stock expected to report next?

The next earning report is scheduled for Feb 23, 2026.

What are the forecasts for GeneDx Holdings Corp. Class A Common Stock's next earnings report?

Based on 10 analysts, GeneDx Holdings Corp. Class A Common Stock is expected to report EPS of $0.10 and revenue of $121.71M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.